Cytosorbents
CTSO
#9719
Rank
โ‚ฌ42.21 M
Marketcap
0,67ย โ‚ฌ
Share price
-3.44%
Change (1 day)
-27.15%
Change (1 year)

Market capitalization of Cytosorbents (CTSO)

Market cap: โ‚ฌ42.21 Million

As of March 2026 Cytosorbents has a market cap of โ‚ฌ42.21 Million. This makes Cytosorbents the world's 9719th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytosorbents from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ42.21 M16.11%
2025โ‚ฌ36.35 M-26.75%
2024โ‚ฌ49.63 M-5.25%
2023โ‚ฌ52.38 M-16.92%
2022โ‚ฌ63.05 M-60.8%
2021โ‚ฌ0.16 B-42.57%
2020โ‚ฌ0.28 B149.85%
2019โ‚ฌ0.11 B-50.05%
2018โ‚ฌ0.22 B44.39%
2017โ‚ฌ0.15 B17.78%
2016โ‚ฌ0.13 B2%
2015โ‚ฌ0.12 B-32.14%
2014โ‚ฌ0.19 B738.14%
2013โ‚ฌ22.74 M7.67%
2012โ‚ฌ21.12 M-3.34%
2011โ‚ฌ21.85 M69.04%
2010โ‚ฌ12.92 M46.88%
2009โ‚ฌ8.8 M508.87%
2008โ‚ฌ1.44 M

End of Day market cap according to different sources

On Mar 10th, 2026 the market cap of Cytosorbents was reported to be:

โ‚ฌ43.71 Million
by Nasdaq info icon info icon
โ‚ฌ42.21 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Boston Scientific
BSX
โ‚ฌ89.22 B 211,275.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚ฌ14.49 B 34,237.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
โ‚ฌ1.27 B 2,931.44%๐Ÿ‡บ๐Ÿ‡ธ USA